EXHIBIT 32.2

        CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with Igene Biotechnology, Inc. (the "Company")
Annual Report on Form 10-K for the fiscal year ended December 31,
2009, as filed with the Securities and Exchange Commission on the
date  hereof  (the  "Report"),  I, Edward  J.  Weisberger,  Chief
Financial  Officer of the Company, certify pursuant to 18  U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:

          (1)  The Report fully complies with the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

          (2)   The  information contained in the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date:  March 31, 2010      By:  /S/ EDWARD J. WEISBERGER
                                _________________________________
                                    EDWARD J. WEISBERGER
                                    Chief Financial Officer
                                    (principal financial officer)

A  signed original of this written statement required by  Section
906  has been provided to the Company and will be retained by the
Company  and furnished to the Securities and Exchange  Commission
or its staff upon request.